menopause Archives -

The first and only body-identical HRT for post-menopausal oestrogen deficiency, Bijuve, has been passed by the SMC as

Scottish Medicines Consortium accepts Theramex’ Bijuve HRT on NHS Scotland

https://pharmaphorum.com/news/scottish-medicines-consortium-accepts-theramex-bijuve-hrt/

Astellas remains on course to be the first drugmaker to bring a new non-hormonal therapy for symptoms of

Astellas files menopause drug fezolinetant in US, setting up Feb verdict

https://pharmaphorum.com/news/astellas-files-menopause-drug-fezolinetant-in-us-setting-up-feb-verdict/

Astellas looks to be in pole position to bring a new non-hormonal therapy for symptoms of menopause to

Astellas’ eyes filings for menopause drug fezolinetant after ph3 win

https://pharmaphorum.com/news/astellas-eyes-filings-for-menopause-drug-fezolinetant-after-ph3-win/

A virtual menopause clinic service developed by Bia Care is starting a randomised clinical trial within the NHS

Bia Care starts NHS trial of its digital menopause platform

https://pharmaphorum.com/news/bia-care-starts-nhs-trial-of-its-digital-menopause-platform/

Digital health startup Bia Care has been awarded additional funding from the NHS to extend the rollout of

Update: Digital health firm Bia Care extends NHS menopause partnership

https://pharmaphorum.com/news/digital-menopause-firm-bia-care-extends-nhs-partnership/

Bayer is to buy UK-based KaNDy Therapeutics in a deal worth more than $800 million, adding the biotech’s

Bayer adds menopause drug to pipeline with KaNDy acquisition

https://pharmaphorum.com/news/bayer-adds-menopause-drug-to-pipeline-with-kandy-acquisition/

Japan’s Astellas has started treating patients in a phase 3 trial of fezolinetant, a non-hormonal drug for menopausal

Astellas pushes non-hormonal menopause drug into phase 3

https://pharmaphorum.com/news/astellas-pushes-non-hormonal-menopause-drug-into-phase-3/

menopause